Drug-Eluting Stent Cost-Effectiveness Potential Realized In Real World
This article was originally published in The Gray Sheet
Executive Summary
Analysis of randomized clinical trials and Medicare cost data confirm earlier predictions that drug-eluting stents are cost-effective, according to David Cohen, MD, Beth Israel Deaconess Hospital
You may also be interested in...
Drug-Eluting Stents Will Pay Their Own Way According To SIRIUS Cost Study
The additional costs associated with implanting Johnson & Johnson/Cordis' Cypher sirolimus-eluting stent instead of a bare metal stent are almost entirely recouped within the first year post-implant, according to a cost-effectiveness analysis of the SIRIUS trial
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.